222 related articles for article (PubMed ID: 34468106)
1. Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging.
Korzhevskii DE; Kirik OV; Guselnikova VV; Tsyba DL; Fedorova EA; Grigorev IP
Eur J Histochem; 2021 Sep; 65(s1):. PubMed ID: 34468106
[TBL] [Abstract][Full Text] [Related]
2. Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits.
Beach TG; Sue LI; Walker DG; Lue LF; Connor DJ; Caviness JN; Sabbagh MN; Adler CH
Acta Neuropathol; 2007 Oct; 114(4):419-24. PubMed ID: 17639428
[TBL] [Abstract][Full Text] [Related]
3. Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.
Plum S; Helling S; Theiss C; Leite REP; May C; Jacob-Filho W; Eisenacher M; Kuhlmann K; Meyer HE; Riederer P; Grinberg LT; Gerlach M; Marcus K
J Proteomics; 2013 Dec; 94():202-206. PubMed ID: 23917253
[TBL] [Abstract][Full Text] [Related]
4. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
[TBL] [Abstract][Full Text] [Related]
5. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
6. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
[TBL] [Abstract][Full Text] [Related]
7. Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes.
Wulf M; Barkovits K; Schork K; Eisenacher M; Riederer P; Gerlach M; Eggers B; Marcus K
J Neural Transm (Vienna); 2022 Oct; 129(10):1257-1270. PubMed ID: 35852604
[TBL] [Abstract][Full Text] [Related]
8. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.
Zecca L; Stroppolo A; Gatti A; Tampellini D; Toscani M; Gallorini M; Giaveri G; Arosio P; Santambrogio P; Fariello RG; Karatekin E; Kleinman MH; Turro N; Hornykiewicz O; Zucca FA
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9843-8. PubMed ID: 15210960
[TBL] [Abstract][Full Text] [Related]
9. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
Biesemeier A; Eibl O; Eswara S; Audinot JN; Wirtz T; Pezzoli G; Zucca FA; Zecca L; Schraermeyer U
J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
[TBL] [Abstract][Full Text] [Related]
10. Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.
Zucca FA; Bellei C; Giannelli S; Terreni MR; Gallorini M; Rizzio E; Pezzoli G; Albertini A; Zecca L
J Neural Transm (Vienna); 2006 Jun; 113(6):757-67. PubMed ID: 16755380
[TBL] [Abstract][Full Text] [Related]
11. The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease.
Nagatsu T; Nakashima A; Watanabe H; Ito S; Wakamatsu K; Zucca FA; Zecca L; Youdim M; Wulf M; Riederer P; Dijkstra JM
J Neural Transm (Vienna); 2023 May; 130(5):611-625. PubMed ID: 36939908
[TBL] [Abstract][Full Text] [Related]
12. Neuromelanin in parkinsonian disorders: an update.
Martin-Bastida A; Pietracupa S; Piccini P
Int J Neurosci; 2017 Dec; 127(12):1116-1123. PubMed ID: 28460588
[TBL] [Abstract][Full Text] [Related]
13. Increases in TH immunoreactivity, neuromelanin and degeneration in the substantia nigra of middle aged mice.
Kim ST; Choi JH; Kim D; Hwang O
Neurosci Lett; 2006 Apr; 396(3):263-8. PubMed ID: 16377085
[TBL] [Abstract][Full Text] [Related]
14. Life span pigmentation changes of the substantia nigra detected by neuromelanin-sensitive MRI.
Xing Y; Sapuan A; Dineen RA; Auer DP
Mov Disord; 2018 Nov; 33(11):1792-1799. PubMed ID: 30423212
[TBL] [Abstract][Full Text] [Related]
15. [Neuromelanin in neurons of substantia nigra lacking tyrosine hydroxylase].
Grigor'ev IP; Sukhorukova EG; Kolos EA; Korzhevskiĭ DE
Morfologiia; 2012; 141(2):65-7. PubMed ID: 22913142
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy.
Miyoshi F; Ogawa T; Kitao SI; Kitayama M; Shinohara Y; Takasugi M; Fujii S; Kaminou T
AJNR Am J Neuroradiol; 2013; 34(11):2113-8. PubMed ID: 23744697
[TBL] [Abstract][Full Text] [Related]
17. Neuromelanin of the human substantia nigra: an update.
Zucca FA; Basso E; Cupaioli FA; Ferrari E; Sulzer D; Casella L; Zecca L
Neurotox Res; 2014 Jan; 25(1):13-23. PubMed ID: 24155156
[TBL] [Abstract][Full Text] [Related]
18. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
[TBL] [Abstract][Full Text] [Related]
19. Neuromelanin imaging analyses of the substantia nigra in patients with Machado-Joseph disease.
Nakata Y; Sakamoto A; Kawata A
Neuroradiology; 2020 Nov; 62(11):1433-1439. PubMed ID: 32556403
[TBL] [Abstract][Full Text] [Related]
20. Ferritin and neuromelanin "quantum dot" array structures in dopamine neurons of the substantia nigra pars compacta and norepinephrine neurons of the locus coeruleus.
Rourk CJ
Biosystems; 2018 Sep; 171():48-58. PubMed ID: 30048795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
